InsiderClue
Insiders · Profile

5AM Ventures IV, L.P.

10% owner at Q32 Bio · 10% owner at IDEAYA Biosciences · Former 10% holder at Aprea Therapeutics · and 1 more. Filing since 20 Jul 2018. CIK 0001589315

FIXX Q32 Bio Inc. 10% owner · 6 trades IDYA IDEAYA Biosciences, Inc. 10% owner · 2 trades APRE Aprea Therapeutics, Inc. Former 10% holder · 5 trades CRNX Crinetics Pharmaceuticals, Inc. Former 10% holder · 4 trades
Company
Date
Role
Action
Shares
Amount
Of holding
FIXX Q32 Bio Inc.
22 Dec 2020
10% owner
Sold, plan not stated
500,000
$6.41M
73.4%
FIXX Q32 Bio Inc.
14 Dec 2020
10% owner
Sold, plan not stated
500,000
$6.13M
71.3%
IDYA IDEAYA Biosciences, Inc.
11 Nov 2020
10% owner
Sold, plan not stated
800,000
$10.93M
89.8%
APRE Aprea Therapeutics, Inc.
5 Oct 2020
Former 10% holder
Sold, plan not stated
175,000
$4.43M
55.8%
APRE Aprea Therapeutics, Inc.
16 Jun 2020
10% owner
Sold, plan not stated
140,000
$4.66M
64.8%
APRE Aprea Therapeutics, Inc.
11 Jun 2020
10% owner
Sold, plan not stated
245,000
$7.04M
75.2%
APRE Aprea Therapeutics, Inc.
19 May 2020
10% owner
Sold, plan not stated
255,000
$8.96M
73.8%
APRE Aprea Therapeutics, Inc.
7 Oct 2019
10% owner
Bought
333,333
$5.00M
opened
CRNX Crinetics Pharmaceuticals, Inc.
21 Jun 2019
Former 10% holder
Sold, plan not stated
250,000
$5.55M
72.6%
IDYA IDEAYA Biosciences, Inc.
28 May 2019
10% owner
Bought
750,000
$7.50M
35.8%
FIXX Q32 Bio Inc.
16 May 2019
10% owner
Sold, plan not stated
615,000
$13.20M
73.5%
CRNX Crinetics Pharmaceuticals, Inc.
18 Mar 2019
10% owner
Sold, plan not stated
154,839
$3.75M
59.7%
CRNX Crinetics Pharmaceuticals, Inc.
22 Jan 2019
10% owner
Sold, plan not stated
262,153
$5.73M
66.9%
FIXX Q32 Bio Inc.
10 Dec 2018
10% owner
Sold, plan not stated
15,575
$405.03K
6.0%
FIXX Q32 Bio Inc.
23 Nov 2018
10% owner
Sold, plan not stated
29,682
$594.71K
10.7%
FIXX Q32 Bio Inc.
16 Nov 2018
10% owner
Sold, plan not stated
525,900
$10.62M
68.0%
CRNX Crinetics Pharmaceuticals, Inc.
20 Jul 2018
10% owner
Bought
115,000
$1.96M
3.5%
17 decisions on file.